Assessment of CCR2 PET as a Biomarker for Head and Neck Squamous Cell Carcinoma.

Saved in:
Bibliographic Details
Title: Assessment of CCR2 PET as a Biomarker for Head and Neck Squamous Cell Carcinoma.
Authors: Li A; Mallinckrodt Institute of Radiology, Washington University in St. Louis, St. Louis, Missouri., Sultan D; Mallinckrodt Institute of Radiology, Washington University in St. Louis, St. Louis, Missouri., Heo GS; Mallinckrodt Institute of Radiology, Washington University in St. Louis, St. Louis, Missouri.; Siteman Cancer Center, Washington University in St. Louis, St. Louis, Missouri., Detering L; Mallinckrodt Institute of Radiology, Washington University in St. Louis, St. Louis, Missouri., Lahad D; Mallinckrodt Institute of Radiology, Washington University in St. Louis, St. Louis, Missouri., Luehmann H; Mallinckrodt Institute of Radiology, Washington University in St. Louis, St. Louis, Missouri., Zhang X; Mallinckrodt Institute of Radiology, Washington University in St. Louis, St. Louis, Missouri., Venkatesan R; Mallinckrodt Institute of Radiology, Washington University in St. Louis, St. Louis, Missouri., Frye J; Mallinckrodt Institute of Radiology, Washington University in St. Louis, St. Louis, Missouri., Belmar J; Department of Medicine, Washington University in St. Louis, St Louis, Missouri., Ramadan S; Department of Otolaryngology, Washington University in St. Louis, St. Louis, Missouri., Crowder R; Department of Otolaryngology, Washington University in St. Louis, St. Louis, Missouri., Nai YH; Mallinckrodt Institute of Radiology, Washington University in St. Louis, St. Louis, Missouri., Tao J; Department of Medicine, University of Missouri, Columbia; Missouri., Gropler R; Mallinckrodt Institute of Radiology, Washington University in St. Louis, St. Louis, Missouri., Laforest R; Mallinckrodt Institute of Radiology, Washington University in St. Louis, St. Louis, Missouri.; Siteman Cancer Center, Washington University in St. Louis, St. Louis, Missouri., Jackson RS; Department of Otolaryngology, Washington University in St. Louis, St. Louis, Missouri.; Robert Ebert and Greg Stubblefield Head and Neck Tumor Center, Siteman Cancer Center, Washington University in St. Louis, St. Louis, Missouri; and., Chernock R; Department of Otolaryngology, Washington University in St. Louis, St. Louis, Missouri.; Department of Pathology and Immunology, Washington University in St. Louis, St. Louis, Missouri., Lin CY; Siteman Cancer Center, Washington University in St. Louis, St. Louis, Missouri.; Department of Pathology and Immunology, Washington University in St. Louis, St. Louis, Missouri., Li S; Siteman Cancer Center, Washington University in St. Louis, St. Louis, Missouri.; Department of Medicine, Washington University in St. Louis, St Louis, Missouri., Puram S; Department of Otolaryngology, Washington University in St. Louis, St. Louis, Missouri.; Robert Ebert and Greg Stubblefield Head and Neck Tumor Center, Siteman Cancer Center, Washington University in St. Louis, St. Louis, Missouri; and., Dehdashti F; Mallinckrodt Institute of Radiology, Washington University in St. Louis, St. Louis, Missouri.; Siteman Cancer Center, Washington University in St. Louis, St. Louis, Missouri., Liu Y; Mallinckrodt Institute of Radiology, Washington University in St. Louis, St. Louis, Missouri; yongjianliu@wustl.edu.; Siteman Cancer Center, Washington University in St. Louis, St. Louis, Missouri.
Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2026 Jul 01; Vol. 67 (7), pp. 1056-1061. Date of Electronic Publication: 2026 Jul 01.
Publication Type: Journal Article
Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1535-5667
DOI:10.2967/jnumed.125.271601